Search for persons
X
?
1
Clinical Remission in Patients Affected by Severe Eosinophi..:
Carla Maria Irene Quarato ; Pasquale Tondo ; Donato Lacedonia...
https://www.mdpi.com/2077-0383/13/1/291. , 2024
https://www.mdpi.com/2077-0383/13/1/291. , 2024
?
2
Image_1_Features of severe asthma response to anti-IL5/IL5r..:
Giovanna Elisiana Carpagnano ; Andrea Portacci ; Santi Nolasco...
doi:10.3389/fimmu.2024.1343362.s002. , 2024
doi:10.3389/fimmu.2024.1343362.s002. , 2024
?
3
Clinical Remission in Patients Affected by Severe Eosinophi..:
Quarato, Carla Maria Irene ; Tondo, Pasquale ; Lacedonia, Donato...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10780210/. , 2024
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10780210/. , 2024
?
4
Table_3_Features of severe asthma response to anti-IL5/IL5r..:
Giovanna Elisiana Carpagnano ; Andrea Portacci ; Santi Nolasco...
doi:10.3389/fimmu.2024.1343362.s004. , 2024
doi:10.3389/fimmu.2024.1343362.s004. , 2024
?
5
DataSheet_1_Features of severe asthma response to anti-IL5/..:
Giovanna Elisiana Carpagnano ; Andrea Portacci ; Santi Nolasco...
doi:10.3389/fimmu.2024.1343362.s001. , 2024
doi:10.3389/fimmu.2024.1343362.s001. , 2024
?
6
Table_6_Features of severe asthma response to anti-IL5/IL5r..:
Giovanna Elisiana Carpagnano ; Andrea Portacci ; Santi Nolasco...
doi:10.3389/fimmu.2024.1343362.s007. , 2024
doi:10.3389/fimmu.2024.1343362.s007. , 2024
?
7
Table_5_Features of severe asthma response to anti-IL5/IL5r..:
Giovanna Elisiana Carpagnano ; Andrea Portacci ; Santi Nolasco...
doi:10.3389/fimmu.2024.1343362.s006. , 2024
doi:10.3389/fimmu.2024.1343362.s006. , 2024
?
8
Table_4_Features of severe asthma response to anti-IL5/IL5r..:
Giovanna Elisiana Carpagnano ; Andrea Portacci ; Santi Nolasco...
doi:10.3389/fimmu.2024.1343362.s005. , 2024
doi:10.3389/fimmu.2024.1343362.s005. , 2024
?
9
Table_3_Features of severe asthma response to anti-IL5/IL5r..:
Giovanna Elisiana Carpagnano ; Andrea Portacci ; Santi Nolasco...
doi:10.3389/fimmu.2024.1343362.s004. , 2024
doi:10.3389/fimmu.2024.1343362.s004. , 2024
?
10
DataSheet_1_Features of severe asthma response to anti-IL5/..:
Giovanna Elisiana Carpagnano ; Andrea Portacci ; Santi Nolasco...
doi:10.3389/fimmu.2024.1343362.s001. , 2024
doi:10.3389/fimmu.2024.1343362.s001. , 2024
?
11
Image_2_Features of severe asthma response to anti-IL5/IL5r..:
Giovanna Elisiana Carpagnano ; Andrea Portacci ; Santi Nolasco...
doi:10.3389/fimmu.2024.1343362.s003. , 2024
doi:10.3389/fimmu.2024.1343362.s003. , 2024
?
12
Table_5_Features of severe asthma response to anti-IL5/IL5r..:
Giovanna Elisiana Carpagnano ; Andrea Portacci ; Santi Nolasco...
doi:10.3389/fimmu.2024.1343362.s006. , 2024
doi:10.3389/fimmu.2024.1343362.s006. , 2024
?
13
Table_5_Features of severe asthma response to anti-IL5/IL5r..:
Giovanna Elisiana Carpagnano ; Andrea Portacci ; Santi Nolasco...
doi:10.3389/fimmu.2024.1343362.s006. , 2024
doi:10.3389/fimmu.2024.1343362.s006. , 2024
?
14
Table_3_Features of severe asthma response to anti-IL5/IL5r..:
Giovanna Elisiana Carpagnano ; Andrea Portacci ; Santi Nolasco...
doi:10.3389/fimmu.2024.1343362.s004. , 2024
doi:10.3389/fimmu.2024.1343362.s004. , 2024
?
15
Image_2_Features of severe asthma response to anti-IL5/IL5r..:
Giovanna Elisiana Carpagnano ; Andrea Portacci ; Santi Nolasco...
doi:10.3389/fimmu.2024.1343362.s003. , 2024
doi:10.3389/fimmu.2024.1343362.s003. , 2024